Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This study found that androgenetic alopecia is a significant yet under-recognized cause of hair loss in children and adolescents, often linked to family history and typically diagnosed by clinical examination.

This study suggests that pediatric androgenetic alopecia is often associated with metabolic syndrome risk factors, highlighting the importance of early diagnosis for potential future health complications.

Standardized treatment protocols are needed for children with androgenetic alopecia.

This review discusses pediatric androgenetic alopecia, emphasizing the diagnostic process and outlining potential treatments, but reports no new clinical results.

This study found that androgenetic alopecia is the leading cause of hair loss in adolescents and may indicate endocrine disorders, emphasizing the need for accurate diagnosis.

The study has limitations, and future research should use better methods to improve treatment for children with hair loss.

In this retrospective study of 133 pediatric patients, topical minoxidil was generally well tolerated for managing androgenetic alopecia, but close monitoring and adherence to treatment, accounting for hormonal and concurrent conditions, were emphasized for effective care.

In this study, low-dose oral minoxidil was found to improve hair density in 80% of pediatric patients with androgenetic alopecia or telogen effluvium, with mild side effects primarily reported.

In this retrospective study from Jiangsu Province Hospital, researchers reported a high prevalence of pediatric androgenetic alopecia in patients under 18, often associated with hormonal imbalances and comorbid conditions, emphasizing the need for individualized treatment plans that prioritize addressing hormonal disorders and comorbidities.

This article discusses androgenetic alopecia, emphasizing its prevalence across age groups and noting that it is the most common cause of hair loss in adolescents, but provides no new clinical results.

In this study, researchers examined vitamin D levels and blood count parameters in children and adolescents with non-scarring alopecia, finding significant vitamin D deficiency but no significant differences in deficiency or insufficiency across different types of alopecia.

This source provides no abstract, offering no results or conclusions on a case involving a 14-year-old boy with abrupt-onset hair changes presented in a photo quiz format in Pediatric Dermatology.

Most young patients found oral minoxidil helpful for hair loss and were willing to continue using it.

The conference highlighted new treatments and research in pediatric skin conditions, emphasizing collaboration and innovation.

This review discusses the skin manifestations associated with metabolic syndrome and related conditions in young populations, noting associations with obesity, insulin resistance, and neonatal obesity, but reports no new clinical results.

The book is a comprehensive and current guide on hair disorders, with minor flaws.

This review highlights the increasing use of trichoscopy, a noninvasive and well-tolerated diagnostic tool, to aid in the accurate diagnosis and management of various pediatric hair and scalp conditions, such as alopecia and other abnormalities.

This study found that the incidence of head and neck melanoma has increased by 51.1% among pediatric, adolescent, and young adult populations in North America over the past 20 years, primarily affecting males aged 15 to 39 years.

This retrospective study conducted at two centers in west Mexico identified distinctive trichoscopic features in pediatric androgenetic alopecia, with 70% of patients being male and most showing vitamin D deficiency; topical minoxidil was effective and well-tolerated as a treatment.

The two lotions used day and night may be a good alternative to minoxidil for hair loss treatment with better cosmetic effects and tolerance.

This review discusses current knowledge on pediatric androgenetic alopecia and reports no new clinical results, highlighting the potential usefulness of topical and oral minoxidil, and topical finasteride.

This review synthesizes recent advancements in clinical trichology, highlighting updates on androgenetic alopecia treatments like low-dose oral minoxidil, 5α-reductase inhibitors, and other therapeutic options for various alopecia types, including telogen/anagen effluvium and alopecia areata, and detailed approaches for scarring alopecias and pediatric trichology.

This review discusses various syndromes and conditions associated with abnormal hair growth, including potential therapies, but reports no new clinical findings or results.

Hair loss is mainly due to genes and hormones, and can be treated with minoxidil and finasteride. Excessive hair growth is linked to certain disorders and can be managed with hormonal therapy and laser hair removal.

This case study describes a 15-year-old girl with progressive hair thinning and reduced hair density at the frontal scalp, with a family history of alopecia.

This review discusses pediatric androgenetic alopecia and reports no clinical results; the authors highlight a need for diagnostic and treatment options, suggesting further research.

In this case report, two adolescents developed androgenetic alopecia after treatment with anastrozole for idiopathic short stature, suggesting this potential side effect should be considered in pediatric patients using aromatase inhibitors.

This review discusses the use of trichoscopy in diagnosing and managing pediatric hair and scalp disorders and reports no new experimental findings.

This review discusses diagnostic strategies for pediatric hair loss, emphasizing the importance of thorough examinations and dermoscopy for accurate diagnosis, and reports no new research findings.

This article reviews the causes of hair loss in pediatric and adult populations, emphasizing the importance of distinguishing between primary dermatologic conditions and those related to systemic diseases, but reports no new clinical findings.